Prosecution Insights
Last updated: October 04, 2026

Medtronic Ireland Manufacturing Unlimited Company

Technology area: Medical Devices & Mechanical Engineering

16 pending office actions • 8 art units • 16 examiners • 0 of 16 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Analysis

Medtronic Ireland Manufacturing Unlimited Company is currently managing 14 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 7 distinct art units, showing a variety of technical focuses within the medical device field. The portfolio involves 14 distinct examiners, which means every pending action is being reviewed by a different person. This ratio of 14 pending office actions to 14 distinct examiners suggests a diversified examination process.

The busiest examiner, BRUTUS, JOEL F, is handling 1 pending office action. Because there are 14 pending office actions and 14 distinct examiners, no single examiner has a larger share of the workload than any other. This distribution across 7 distinct art units suggests that while the technical areas are somewhat concentrated, the individual examiner perspectives the company must address are varied. Managing 14 distinct examiners requires the company to adapt its arguments to 14 different individual styles within the Medical Devices & Mechanical Engineering sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

16
Total Pending OAs
9
Non-Final OAs
5
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (38%)
9
Medium (56%)
1
Easy (6%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (19%)
§103 only8 (50%)
§102 only1 (6%)
§112 only1 (6%)
Multi-statute (no §101)3 (19%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
6% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
11
Mechanical / Eng
69% of docket
4
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

160 h
Manual time on pending OAs
32 h
Time saved (low, 20%)
56 h
Time saved (mid, 35%)
1.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRUTUS, JOEL F 1 72.8% +17.7%
NASSER, ROBERT L 1 72.9% +11.2%
CERIONI, DANIEL LEE 1 64.5% +28.0%
ALTER MORSCHAUSER, ALYSSA MARGO 1 76.5% +15.8%
OUYANG, BO 1 60.6% +8.8%
COLLINS, SEAN W 1 74.7% +26.7%
FLANAGAN, BEVERLY MEINDL 1 73.0% +20.4%
VAHDAT, KHADIJEH A 1 79.5% +20.1%
EDOUARD, JONATHAN CHRISTOPHER 1 22.8% +36.9%
STEINBERG, AMANDA L 1 51.3% +27.0%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18738238 MICROPHONE BRUIT SENSING FOR CRYOABLATION BALLOON CATHETERS FLANAGAN, BEVERLY MEINDL 8d overdue
18649578 REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION EDOUARD, JONATHAN CHRISTOPHER 83d
19471252 FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION BRUTUS, JOEL F —
19109478 IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY CERIONI, DANIEL LEE —
18582754 SELECTION OF DENERVATION THERAPY STEINBERG, AMANDA L —
18577342 CRYOTHERAPEUTIC TREATMENT DEVICES STOKLOSA, JOSEPH A —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18738238 MICROPHONE BRUIT SENSING FOR CRYOABLATION BALLOON CATHETERS FLANAGAN, BEVERLY MEINDL 8d overdue
18649578 REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION EDOUARD, JONATHAN CHRISTOPHER 83d
19471252 FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION BRUTUS, JOEL F —
19129470 CRYOABLATION CATHETER WITH VARYING CROSS-SECTIONAL SHAPE NASSER, ROBERT L —
19109478 IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY CERIONI, DANIEL LEE —
19029521 CATHETER APPARATUSES HAVING MULTI-ELECTRODE ARRAYS FOR RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS ALTER MORSCHAUSER, ALYSSA MARGO —
18806111 SYSTEMS AND METHODS FOR EVALUATING NEUROMODULATION THERAPY VIA HEMODYNAMIC RESPONSES COLLINS, SEAN W —
18669595 AMPLITUDE MODULATION TO ASSESS CATHETER ENVIRONMENT VAHDAT, KHADIJEH A —

Top Art Units

Art UnitApps
3794 7
3797 1
3992 1
3683 1
3792 1
3993 1
3771 1
1796 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19471252 FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION BRUTUS, JOEL F 3797 §102§103 Non-Final OA — Pending Sep 30, 2025
19129470 CRYOABLATION CATHETER WITH VARYING CROSS-SECTIONAL SHAPE NASSER, ROBERT L 3992 §103 Non-Final OA — Pending May 13, 2025
19109478 IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY CERIONI, DANIEL LEE — §101§112 Non-Final OA — Pending Mar 06, 2025
19029521 CATHETER APPARATUSES HAVING MULTI-ELECTRODE ARRAYS FOR RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS ALTER MORSCHAUSER, ALYSSA MARGO — §112Other Non-Final OA — Pending Jan 17, 2025
18841996 NEUROMODULATION CATHETER OUYANG, BO 3794 §103 Final Rejection — Pending Aug 27, 2024
18806111 SYSTEMS AND METHODS FOR EVALUATING NEUROMODULATION THERAPY VIA HEMODYNAMIC RESPONSES COLLINS, SEAN W 3794 §103 Final Rejection — Pending Aug 15, 2024
18738238 MICROPHONE BRUIT SENSING FOR CRYOABLATION BALLOON CATHETERS FLANAGAN, BEVERLY MEINDL 3794 §102§103 Non-Final OA 8d overdue Pending Jun 10, 2024
18669595 AMPLITUDE MODULATION TO ASSESS CATHETER ENVIRONMENT VAHDAT, KHADIJEH A 3794 §102 Non-Final OA — Pending May 21, 2024
18649578 REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION EDOUARD, JONATHAN CHRISTOPHER 3683 §101§102§103 Non-Final OA 83d Pending Apr 29, 2024
18582754 SELECTION OF DENERVATION THERAPY STEINBERG, AMANDA L 3792 §101§103 Non-Final OA — Pending Feb 21, 2024
18577342 CRYOTHERAPEUTIC TREATMENT DEVICES STOKLOSA, JOSEPH A 3794 §102§103 Final Rejection — Pending Jan 08, 2024
18377585 INTRACARDIAC TOOLS AND METHODS FOR DELIVERY OF ELECTROPORATION THERAPIES KADING, JOSHUA A 3993 §103 Non-Final OA 69d Pending Oct 06, 2023
18264995 DEVICES AND METHODS FOR DETERMINING RENAL ARTERIOLAR VASOMOTION BORSCH, NICHOLAS S 3794 §103 Final Rejection 14d Pending Aug 10, 2023
18333274 INTEGRATED CHECK VALVE FOR HEATING ELEMENT COOLING IN OCCLUSIVE DENERVATION CATHETERS RABAGLIA, BRIDGET ELIZABETH 3771 §103 Final Rejection — Pending Jun 12, 2023
17820728 MIMICKING PHYSIOLOGIC CONDITIONS DURING ORGAN OR TISSUE PERFUSION MARCHESCHI, MICHAEL A 1796 §103 Non-Final OA — Pending Aug 18, 2022
17038336 HELICAL PUSH WIRE ELECTRODE DELLA, JAYMI E 3794 §103 Non-Final OA — Pending Sep 30, 2020

Managing Medtronic Ireland Manufacturing Unlimited Company's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month